Cargando…
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia
CD5-expressing B lymphocytes from patients with selected chronic lymphoproliferative disorders were used to determine whether monoclonal populations of CD5+ human B cells produce autoantibodies. CD5+ B cells from 19 patients with chronic lymphocytic leukemia (CLL) and one with diffuse well-different...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189197/ https://www.ncbi.nlm.nih.gov/pubmed/2462608 |
Ejemplares similares
-
Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia
Publicado: (1982) -
Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia
por: Jovanovic, Danijela, et al.
Publicado: (2014) -
Paraneoplastic pemphigus with anti-desmocollin 3 autoantibodies and chronic lymphocytic leukemia
por: Adaszewska, Alicja, et al.
Publicado: (2018) -
Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia
por: Abdelgader, Enaam Abdelrhman, et al.
Publicado: (2018) -
CD19-Regulated Signaling Thresholds Control Peripheral Tolerance and Autoantibody Production in B Lymphocytes
por: Inaoki, Makoto, et al.
Publicado: (1997)